The ODC is seeking comments on a review of the structure, design and administrative processes relating to medicinal cannabis related permits

On 1 November 2020 cost recovery arrangements for the Medicinal Cannabis Scheme in the Narcotic Drugs Act 1967 will change to introduce fees and charges for cannabis-related manufacture licences and permits granted under the Scheme.

The Narcotic Drugs Regulation 2016 prescribes fees for various applications relating to medicinal cannabis made under the Narcotic Drugs Act 1967

The Australian Government will boost the nation's medicinal cannabis industry by prioritising projects that have been granted Major Project Status (MPS) and ultimately driving economic growth.